Computer-aided diagnosis (CAD) is an attractive topic in Alzheimer's disease (AD) research. Many algorithms are based on a relatively large training dataset. However, small hospitals are usually unable to collect sufficient training samples for robust classification. Although data sharing is expanding in scientific research, it is unclear whether a model based on one dataset is well suited for other data sources. Using a small dataset from a local hospital and a large shared dataset from the AD neuroimaging initiative, we conducted a heterogeneity analysis and found that different functional magnetic resonance imaging data sources show different sample distributions in feature space. In addition, we proposed an effective knowledge transfer method to diminish the disparity among different datasets and improve the classification accuracy on datasets with insufficient training samples. The accuracy increased by approximately 20% compared with that of a model based only on the original small dataset. The results demonstrated that the proposed approach is a novel and effective method for CAD in hospitals with only small training datasets. It solved the challenge of limited sample size in detection of AD, which is a common issue but lack of adequate attention. Furthermore, this paper sheds new light on effective use of multi-source data for neurological disease diagnosis.
基金:
National Natural Science Foundation of China [61473131, 61502187, 81401389]; International Science and Technology Cooperation Program of Hubei Province, China [2017AHB051]; HUST Interdisciplinary Innovation Team Foundation [2016JCTD120]; Alzheimer's Disease Neuroimaging Initiative (ADNI), National Institutes of Health [U01 AG024904]; DOD ADNI, Department of Defense [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche, Ltd.; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO, Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|2 区工程技术
小类|2 区计算机:信息系统2 区计算机:跨学科应用2 区数学与计算生物学2 区医学:信息
最新[2025]版:
大类|2 区医学
小类|1 区计算机:信息系统1 区数学与计算生物学1 区医学:信息2 区计算机:跨学科应用
JCR分区:
出版当年[2017]版:
Q1COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONSQ1MEDICAL INFORMATICSQ1MATHEMATICAL & COMPUTATIONAL BIOLOGYQ1COMPUTER SCIENCE, INFORMATION SYSTEMS
第一作者单位:[1]Huazhong Univ Sci & Technol, Sch Automat, Image Proc & Intelligent Control Key Lab Educ, Minist China, Wuhan 430074, Hubei, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Li Wei,Zhao Yifei,Chen Xi,et al.Detecting Alzheimer's Disease on Small Dataset: A Knowledge Transfer Perspective[J].IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS.2019,23(3):1234-1242.doi:10.1109/JBHI.2018.2839771.
APA:
Li, Wei,Zhao, Yifei,Chen, Xi,Xiao, Yang&Qin, Yuanyuan.(2019).Detecting Alzheimer's Disease on Small Dataset: A Knowledge Transfer Perspective.IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS,23,(3)
MLA:
Li, Wei,et al."Detecting Alzheimer's Disease on Small Dataset: A Knowledge Transfer Perspective".IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS 23..3(2019):1234-1242